In this review, scientists provide a neurobiological overview of key neurological disorders and describe the different types of nanomaterials in use. They present many of the different applications that advances in nanotechnology are having in the field of neurological sciences and discuss the issue of toxicity of the nanomaterials.
Researchers are working on bridging the gap where artificial meets biological - harnessing biological rules to exchange information between the biochemistry of our bodies and the chemistry of our devices. Peptides can provide just such a link.
The EU FP7 Sustainable Nanotechnologies (SUN) Project is coming to its end in March 2017. The project has designed its final events to serve as an effective platform to communicate the main results achieved in its course within the Nanosafety community and bridge them to a wider audience addressing the emerging risks of Key Enabling Technologies (KETs).
The results from the 3rd SUN annual meeting showed great advancement of the project. The meeting was held in Edinburgh, Scotland, UK on 4-5 October 2016 where the project partners presented the results obtained during the second reporting period of the project.
Artificial muscles made significant gains when a literal twist in the development approach uncovered the tensile or stretchy abilities of polymer fibers once they were twisted and coiled into a spring-like geometry. Now, researchers have improved these tensile properties even further by focusing on the thermal properties of the polymer fiber and the molecular structure that makes best use of the chiral configuration.
If drugs could be targeted to exactly the right place in the body, we could probably do with significantly smaller doses - and consequently fewer side effects. To allow for such precise delivery, we need tiny nanocarriers and even smaller nanotrackers to monitor them. Researchers are working on both of these.